Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting up to 20% of the pediatric population associated with alteration of skin and gut microbiome. Probiotics have been proposed for AD treatment. The ProPAD study aimed to investigate the therapeutic effects of the probiotic Lacticaseibacillus rhamnosus GG (LGG) in children with AD.

Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial

Carucci, Laura;Nocerino, Rita;Paparo, Lorella;De Filippis, Francesca;Coppola, Serena;Giglio, Veronica;Cozzolino, Tommaso;Valentino, Vincenzo;Sequino, Giuseppina;Bedogni, Giorgio;Russo, Roberto;Ercolini, Danilo;Berni Canani, Roberto
2022

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting up to 20% of the pediatric population associated with alteration of skin and gut microbiome. Probiotics have been proposed for AD treatment. The ProPAD study aimed to investigate the therapeutic effects of the probiotic Lacticaseibacillus rhamnosus GG (LGG) in children with AD.
File in questo prodotto:
File Dimensione Formato  
Pediatric Allergy Immunology - 2022 - Carucci - Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 879.39 kB
Formato Adobe PDF
879.39 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/899244
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact